PolyPid Ltd
NASDAQ:PYPD

Watchlist Manager
PolyPid Ltd Logo
PolyPid Ltd
NASDAQ:PYPD
Watchlist
Price: 3.97 USD 1.28% Market Closed
Market Cap: 62.1m USD

Operating Margin
PolyPid Ltd

0%
Current
0%
Average
6%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-32.7m
/
Revenue
0

Operating Margin Across Competitors

No Stocks Found

PolyPid Ltd
Glance View

Market Cap
66m USD
Industry
Pharmaceuticals

PolyPid Ltd. is a clinical stage biopharmaceutical company focusing on the development, manufacture, and commercialization of administered therapies to improve surgical outcomes. The firm focuses on the development, production and commercialization of new, locally administered therapies to improve surgical results. The main product is PLEX technology, which is located in the place of surgery and ensures controlled and continuous delivery of medicines.

PYPD Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
0%
=
Operating Profit
-32.7m
/
Revenue
0
What is the Operating Margin of PolyPid Ltd?

Based on PolyPid Ltd's most recent financial statements, the company has Operating Margin of 0%.

Back to Top